title: [Guillain-Barré syndrome with preserved reflexes].
abstract: Guillain-Barré is a rare, autoimmune disease of the peripheral nervous system. It can affect all ages beginning in the intrauterine or neonatal period. Clinical forms are diverse and include acute motor axonal neuropathy (AMAN). We report on a pediatric case of AMAN. A 2.5-year-old child presented with acute flaccid paralysis and preserved reflexes. Etiologic investigations argued in favor of Guillain-Barré syndrome in its AMAN form. Treatment based on IV immunoglobulins resulted in a total decline of paralysis and motor recovery. The AMAN form of Guillain-Barré syndrome should be considered as a potential diagnosis in all cases of acute flaccid paralysis with preserved reflexes.
authors.affiliation: Service de pédiatrie, hôpital militaire d'instruction Mohammed V, Hay Riyad, Rabat, Maroc. Electronic address: dr.zouiri@gmail.com.
authors.forename: G
authors.initials: G
authors.lastname: Zouiri
authors.affiliation: Service de pédiatrie, hôpital militaire d'instruction Mohammed V, Hay Riyad, Rabat, Maroc.
authors.forename: R
authors.initials: R
authors.lastname: Abilkassem
authors.affiliation: Service de neurophysiologie, hôpital militaire d'instruction Mohammed V, Hay Riyad, Rabat, Maroc.
authors.forename: A
authors.initials: A
authors.lastname: Zerhouni
authors.affiliation: Service de pédiatrie, hôpital militaire d'instruction Mohammed V, Hay Riyad, Rabat, Maroc.
authors.forename: N
authors.initials: N
authors.lastname: Dini
authors.affiliation: Service de pédiatrie, hôpital militaire d'instruction Mohammed V, Hay Riyad, Rabat, Maroc.
authors.forename: A
authors.initials: A
authors.lastname: Agadr
mesh_terms: D002675:Child, Preschool; D005260:Female; D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage*; D010243:Paralysis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors